View Document Preview and Link Document Date: 2012-05-02 04:53:39 Open Document File Size: 73,59 KB Share Result on Facebook
City Irvine / NOTTINGHAM / / Company Novozymes A/S / Neomend Inc. / / Continent Europe / / Country United States / United Kingdom / Denmark / / / Event Business Partnership / / IndustryTerm chemical composition / consistent biopharmaceutical components / sustainable solutions / medical device products / medical device applications / adhesion prevention products / / Organization China Zhu Xiaoqing Office / US Paige Donnelly Office / MEDIA CONTACTS INVESTOR CONTACTS Europe René Tronborg Office / European Union / / Person David Renzi / Dermot Pearson / Zhu Xiaoqing / Paige Donnelly / Thomas Steenbech Bomhoff / Niklas Andersson / / / Position Director / Novozymes Biopharma / Marketing / leader / Manager NLAN@novozymes.com Tel. / President and CEO / Global Communications Manager / Director / Novozymes Biopharma Marketing / / Product Albucult / Progel Adhesion Barrier Sealant / / ProvinceOrState California / / URL www.biopharma.novozymes.com / www.neomend.com / www.novozymes.com / / SocialTag 
Novozymes’ rAlbumin supports faster time to market for Neomend adhesion barrier sealant NOTTINGHAM, UK – May 2, 2012 – Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has announced that